Bill Title: A bill to require guidance on how the Food and Drug Administration will consider claims of opioid sparing and on the conditions under which the Food and Drug Administration will consider misuse and abuse of drugs in making certain determinations of safety.
Spectrum: Bipartisan Bill
Status: (Introduced - Dead) 2018-04-12 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
[SB2665 Detail]
Bill Drafts
| Revision | Date | Format | Source | View |
|---|
| Introduced | 2018-04-19 | PDF | Link | View |
Amendments
| Amendment | Date | Disposition | Format | Source | View |
|---|
| No bill amendments currently on file for US Congress SB2665 |
Supplemental Documents
| Title | Description | Date | Format | Source | View |
|---|
| No supplemental documents for US Congress SB2665 currently on file. |
Social Comments on US SB2665
